Endometrial hyperplasia screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Swathi Venkatesan, M.B.B.S.[2]
Oveview
Oveview
Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended.
Screening
Screening
- Women receiving unopposed estrogens should undergo endometrial sampling once every 2 years. [1]
- Particularly if endometrial hyperstimulation was documented previously and is not been treated by short-term progestins.
- If high-risk individual requests an endometrial evaluation before or during HRT.
- Women at high risk for endometrial carcinoma, such as history of Lynch II syndrome.
References
References
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH